Convelo Therapeutics

Convelo Therapeutics is a company that provides medicines focusing on the regenerative capacity of the central nervous system. It develops drugs to regenerate the protective myelin coating around nerve cells and restore function in patients with neurological disorders. The company focuses on multiple sclerosis, pediatric leukodystrophies, traumatic injury, and age-related pathologies such as Alzheimer’s.